Literature DB >> 15289890

The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.

Yuji Tanigaki1, Yoji Nagashima, Yoshiaki Kitamura, Hideki Matsuda, Yasukazu Mikami, Mamoru Tsukuda.   

Abstract

We determined whether the expression of VEGF-A and -C and their receptors, Flt-1 and Flt-4, are associated with primary tumor size, regional lymph node metastasis, distant metastasis and prognosis in patients with tongue carcinoma. The expression of VEGF-A and -C, and their receptors, Flt-1 and Flt-4, in biopsy specimens taken from 73 patients with tongue carcinoma were examined by immunohistochemical staining. VEGF-A expression was associated with distant failure and VEGF-C expression correlated with locoregional recurrence and distant failure. Furthermore, VEGF-C expression was associated with lymph node recurrence in N0 cases. Multivariate analysis revealed that VEGF-C expression was an exclusively independent factor influencing lymph node metastasis. In terms of the overall 5-year survival rate, there was no significance correlation between the overall 5-year survival rate and expression of VEGF-A, Flt-1 and Flt-4 expression, whereas there was a significant difference between VEGF-C-positive and VEGF-C-negative cases (VEGF-C-positive, 51.7% vs VEGF-C-negative, 94.2%). Furthermore, there was a significant difference between positive and negative expression for both VEGF-A and VEGF-C. Multivariate analysis revealed that lymph node metastasis and VEGF-C expression were exclusive, independent factors influencing the overall survival rate. VEGF-C expression may be a predictive factor of regional lymph node recurrence and prognosis in patients with tongue carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289890

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Authors:  Dirk Rades; Cornelia Setter; Juergen Dunst; Olav Dahl; Steven E Schild; Frank Noack
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

3.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

4.  Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.

Authors:  Supurna Ghosh; Jennifer Koblinski; Jeffrey Johnson; Yueying Liu; Aaron Ericsson; J Wade Davis; Zonggao Shi; Matthew J Ravosa; Susan Crawford; Shellaine Frazier; M Sharon Stack
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

5.  Expression and clinical significance of vascular endothelial growth factor and fms-related tyrosine kinase 1 in colorectal cancer.

Authors:  Linchun Wen; Rui Wang; Xiyan Lu; Chuanwen You
Journal:  Oncol Lett       Date:  2015-03-04       Impact factor: 2.967

6.  Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  N D Seibold; S E Schild; K L Bruchhage; M P Gebhard; F Noack; D Rades
Journal:  Strahlenther Onkol       Date:  2013-06-09       Impact factor: 3.621

Review 7.  Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review.

Authors:  Carolin M Grimminger; Peter V Danenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-09       Impact factor: 2.503

8.  The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue.

Authors:  Daisuke Sano; Sungweon Choi; Zvonimir Luka Milas; Ge Zhou; Chad E Galer; Ying-Wen Su; Maria Gule; Mei Zhao; Zhenping Zhu; Jeffrey N Myers
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-04

9.  Phase II study of sunitinib malate in head and neck squamous cell carcinoma.

Authors:  Nicholas W Choong; Mark Kozloff; David Taber; H Shawn Hu; James Wade; Percy Ivy; Theodore G Karrison; Allison Dekker; Everett E Vokes; Ezra E W Cohen
Journal:  Invest New Drugs       Date:  2009-08-04       Impact factor: 3.850

10.  Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.

Authors:  George Pentheroudakis; Nikolaos Angouridakis; Ralph Wirtz; Angelos Nikolaou; Konstantine T Kalogeras; Nicholas Pavlidis; George Fountzilas
Journal:  J Oncol       Date:  2009-10-07       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.